rediff.com

News APP

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

Sign in  |  Create a Rediffmail account

azd1222

Subscribe via RSS
Rediff.com  »  News  »   azd1222

  News for azd1222

  • News
  • Business

AstraZeneca's COVID-19 Vaccine: The TTS Factor

 'It is admitted that the AZ vaccine can, in very rare cases, cause TTS.' IMAGE: A vial labelled 'AstraZeneca COVID-19 Vaccine'. Photograph: Illustration/Dado Ruvic/Reuters   The controversial......

Zydus Cadila to begin vaccine trials for kids above 5 yrs soon

 So far, no other vaccine has been approved globally for children below 12 years.Sohini Das reports.  IMAGE: A beneficiary receives a dose of the Covid-19 vaccine at a vaccination centre in......

Oxford/AstraZeneca COVID-19 vaccine approved by UK regulator

 The coronavirus vaccine designed by scientists at the University of Oxford and produced by AstraZeneca was on Wednesday approved for human use by the United Kingdom’s independent regulator.......

UK hospital told to prep for COVID vaccine by Nov: Report

 A major London hospital trust has been told to be ready to receive the first batches of the COVID-19 vaccine being trialled by Oxford University and AstraZeneca by early next month, according to a......

Serum Inst to resume Covid vaccine trials after DCGI nod

 Serum Institute of India will resume clinical trials of AstraZeneca's COVID-19 vaccine candidate after getting the permission from the Drugs Controller General of India (DCGI), the Pune-based......

Serum Institute to provide Covid vaccine at Rs 250 a dose

 Serum Institute of India plans to make 300 million doses of AZD1222 by December, and will begin phase-2 trials soon. It has also tied up with Novavax for development and commercialisation of its......

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

 The institute expects to complete both, phase-2 and 3 trials in India by the end of this year. Pune's Serum Institute of India (SII) is all set to start phase-2 clinical trials of the Oxford......

Meet Adar Poonawala, India's COVID-19 vaccine man

 Serum Institute is investing $200 million to create capacities for the COVID-19 vaccine.Sohini Das profiles its 39-year-old CEO. IMAGE: Adar Poonawalla, right, and his father Dr Cyrus S......

'We will price Covid vaccine below Rs 1,000'

 'Once the trials are successful in India and the UK, we are certain that COVISHIELD will be one of the first vaccines to be introduced.' IMAGE: The Reference Center for Special Immunobiologicals......

Top Coverage News

World Test Championship 2023

 India held the top position in the ICC Men's Test Team Rankings while Australia secured the...

Manipur's Tragedy

 Here are news, updates and coverage from violence hit Manipur.

IPL 2023

 Complete coverage of IPL 2023

Sri Lanka's Tour of India 2023

 Complete Coverage of Indian cricket team's encounter with Sri Lanka during 3rd Jan - 15th Jan 2023.

GUJARAT, HIMACHAL GO TO POLLS

 The Bharatiya Janata Party was on Thursday poised for a landslide victory in Gujarat to retain...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
rediff on the net© 2025 Rediff.com - Investors - Advertise - Disclaimer - Privacy - Feedback - About us | Terms of use - Grievances